- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/04 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 239/04
Total number of patents in this class: 78
10-year publication summary
|
2
|
6
|
2
|
3
|
5
|
7
|
5
|
7
|
6
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Contemporary Amperex Technology (Hong Kong) Limited | 3546 |
13 |
| Abbvie Inc. | 1800 |
5 |
| Firmenich SA | 1684 |
3 |
| Avexxin AS | 46 |
2 |
| Cameron International Corporation | 1332 |
2 |
| Clariant International Ltd. | 937 |
2 |
| Curza Global, LLC | 29 |
2 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 29 |
2 |
| Neuropro Therapeutics, Inc. | 20 |
2 |
| University of Utah Research Foundation | 1807 |
2 |
| Bristol-myers Squibb Company | 4898 |
1 |
| Boehringer Ingelheim International GmbH | 4650 |
1 |
| Canon Inc. | 39888 |
1 |
| Centre National de La Recherche Scientifique | 10418 |
1 |
| Cheil Industries Inc. | 856 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5658 |
1 |
| Actar AB | 1 |
1 |
| Beijing Tide Pharmaceutical Co. Ltd. | 92 |
1 |
| BRANDEIS University | 334 |
1 |
| Csir | 185 |
1 |
| Other owners | 33 |